Results 151 to 160 of about 30,437 (208)

The Pitfalls of Calcitonin as a Tumor Marker: Real-Life Data of Patients with Elevated Basal Calcitonin Levels but Without Evidence of Medullary Thyroid Carcinoma. [PDF]

J Clin Med
Lederer AK, Kessler CJ, Bouzakri N, Lozan O, Wild F, Rauschkolb-Olk KT, Rossmann H, Lang H, Musholt TJ.   +8 more
europepmc   +1 more source

Systemic therapies for medullary thyroid carcinoma: state of the art. [PDF]

Ther Adv Endocrinol Metab
Román-González A, Califano I, Concepción-Zavaleta M, Pitoia F, Salgado SA.   +4 more
europepmc   +1 more source

Differentiating medullary thyroid carcinoma from papillary thyroid carcinoma using ultrasound viscosity imaging: a preliminary study. [PDF]

BMC Med Imaging
Zhang Q, Zhou W, Xu S, Hua S, Wang R, Yang Z, Zhou J, Gao L, Zhan W.   +8 more
europepmc   +1 more source

Comment on "Evaluating the necessity of prophylactic lateral neck dissection in medullary thyroid carcinoma based on preoperative calcitonin levels: a multicenter retrospective cohort study". [PDF]

Int J Surg
Chen Y, Hong S, Chen Y.
europepmc   +1 more source

A Case of Micro-medullary Thyroid Carcinoma Presenting as Cancer of Unknown Primary. [PDF]

Cureus
Seguchi K, Enokida T, Oba T, Yoshikawa AL, Nakatake N, Yu O.   +5 more
europepmc   +1 more source

Diagnostic advances in medullary thyroid carcinoma. [PDF]

Endocr Oncol
Petranović Ovčariček P, Giovanella L.
europepmc   +1 more source

A Unique Case of Medullary Thyroid Carcinoma in the Background of Hashimoto's Thyroiditis. [PDF]

Clin Case Rep
Khan A, Malik A, Antar M.
europepmc   +1 more source

Detection of SEZ6, a Therapeutic Target, in Medullary Thyroid Carcinoma.

J Clin Endocrinol Metab
Xu B, Baine MK, Jungbluth A, Alabkaa A, Serrette R, Roy D, Rudin CM, Ho AL, Sherman E, Dogan S, Ganly I, Rekhtman N, Ghossein R.   +12 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Medullary thyroid carcinoma

Current Opinion in Endocrinology, Diabetes & Obesity, 2021
Purpose of review To summarize recent developments in the diagnosis and management of patients with medullary thyroid cancer (MTC), with a focus on pathogenesis, systemic therapy, and future directions. Recent findings The addition of mutational analysis to cytological assessment of
Tania, Jaber, Ramona, Dadu, Mimi I, Hu
openaire   +2 more sources